Predicting the 30-year risk of cardiovascular disease: The framingham heart study

Circulation

Volumn 119, Issue 24, 2009, Pages 3078-3084

  Pencina, Michael J ^a,b,c   D'Agostino, Ralph B ^a,b,c   Larson, Martin G ^a,c   Massaro, Joseph M ^a,b,c   Vasan, Ramachandran S ^b,c  

^a SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c FRAMINGHAM HEART STUDY   (United States)

Author keywords

Atherosclerosis; Competing risk; Lifetime risk; Obesity; Risk factors

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALGORITHM; ANTIHYPERTENSIVE THERAPY; ARTICLE; CALIBRATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DIABETES MELLITUS; FEMALE; FOLLOW UP; GENDER; HEART DEATH; HEART INFARCTION; HUMAN; INCIDENCE; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; STROKE; SURVIVAL; SYSTOLIC BLOOD PRESSURE; VALIDATION PROCESS;

ADULT; ALGORITHMS; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LIFE EXPECTANCY; MALE; MASSACHUSETTS; MIDDLE AGED; MODELS, THEORETICAL; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEX FACTORS; TIME FACTORS;

EID: 67649516627     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.816694     Document Type: Article

References (50)

1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
2. Anderson KM, Odell PM, Wilson PWF, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991;121:293-298.
3. Wilson PWF, D'Agostino RB, Levy D, Belanger A, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847.
4. D'Agostino RB, Russell MW, Huse DM, Ellison RC, Silbershatz H, Wilson PFW, Hartz SC. Primary and subsequent coronary risk appraisal: new results from the Framingham Study. Am Heart J. 2000;139:272-281.
5. D'Agostino RB, Wolf PA, Belanger A, Kannel WB. Stroke risk profile: adjustment for antihypertensive medication. Stroke. 1994;25:40-43.
6. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) Study. Circulation. 2002;105:310-315.
7. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, DeBacker G, DeBacquer D, Ducimetiere P, Jousilahti P, Keil U, Njolstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wil-helmsen L, Graham IM. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987-1003.
8. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ. 2007;335:136.
9. Menotti A, Lanti M, Gabiti-Rosei E, Carratelli L, Cavera G, Dormi A, Gaddi A, Mancini M, Motolese M, Muiesan ML, Muntoni S, Notar-bartolo A, Prati P, Remiddi S, Zanchetti A. Riskard 2005: new tools for prediction of cardiovascular disease risk derived from Italian population studies. Nutr Metab Cardiovasc Dis. 2005;15:426-40.
10. Ridker PM, Buring JE, Rifai N, Cook RN. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds risk score. JAMA. 2007;297:611-619.
11. Woodward M, Brindle P, Tunstall-Pedoe, for the SIGN Group on Risk Estimation. Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart. 2007;93:172-176.
12. D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain MR, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care. Circulation. 2008;117:743-753.
13. Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR. The Reynolds risk score for men. Circulation. 2008;118:2243-2251.
14. Grundy SM, Pasternak R, Greenland P, Smith S, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations. Circulation. 1999;100:1481-1492.
15. Lloyd-Jones DM, Wilson PFW, Larson MG, Leip E, Beiser A, D'Agostino RB, Cleeman JI, Levy D. Lifetime risk of coronary heart disease by cholesterol levels at selected ages. Arch Intern Med. 2003; 163:1966-1972.
16. Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D'Agostino RB, Kannel WB, Murabito JM, Vasan RS, Benjamin EJ, Levy D. Lifetime risk for developing congestive heart failure. Circulation. 2002;106: 3068-3072.
17. Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kennel WB, Wolf PA. The lifetime risk of stroke: estimates from the Framingham Study. Stroke. 2006;37:345-350.
18. Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D'Agostino RB, Levy D. Residual lifetime risk of developing hypertension in middle-aged women and men. JAMA. 2002;287:1003-1010.
19. Vasan RS, Pencina MJ, Cobain MR, Freiberg MS, D'Agostino RB. Estimated risks for developing obesity in the Framingham Heart Study. Ann Intern Med. 2005;143:473-480.
20. Cobain MR, Pencina MJ, D'Agostino RB, Vasan RS. Lifetime risk for developing dyslipidemia: the Framingham Offspring Study. Am J Med. 2007;120:623-630.
21. Narayan KMV, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA. 2003;290: 1884-1890.
22. Pekkanen J, Nissinen A, Puska P, Punsar S, Karvonen M. Risk factors and 25 year risk of coronary heart disease in a male population with a high incidence of the disease: the Finnish cohorts of the Seven Countries Study. BMJ. 1989;299:81-85.
23. Lloyd-Jones DM, Leip EP, Larson MG, D'Agostino RB, Beiser A, Wilson PFW, Wolf PA, Levy D. Prediction of lifetime risk of cardiovascular disease by risk factor burden at 50 years of age. Circulation. 2006;113:791-798.
24. Lloyd-Jones DM, Dyer AR, Wang K, Daviglus ML, Greenland P. Risk factor burden in middle age and lifetime risks for cardiovascular and non-cardiovascular death (Chicago Heart Association Detection Project in Industry). Am J Cardiol. 2007;99:535-540.
25. Daviglus ML, Stampler J, Pirzada A, Yan LL, Garside DB, Liu K, Wang K, Dyer AR, Lloyd-Jones DM, Greenland P. Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality. JAMA. 2004;292:1588-1592.
26. Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, Garside DB, Wilson PFW. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA. 2003;290:891-897.
27. Blumenthal RS, Michos ED, Nasir K. Further improvements in CHD risk prediction for women. JAMA. 2007;297:641-643.
28. Sniderman AD, Furberg CD. Age as a modifiable risk factor for cardiovascular disease. Lancet. 2008;371:1547-1549.
29. D'Agostino RB, Grundy S, Sullivan LM, Wilson PWF. Validation of the Framingham coronary heart disease prediction scores. JAMA. 2001;286: 180 -187.
30. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families: the Framingham Offspring Study. Am J Epidemiol. 1979;110:281-290.
31. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem. 1972;18:499 -502.
32. Cox DR. Regression models and life tables. J Roy Stat Soc B. 1972;34: 187-220.
33. Andersen PK, Borgan O, Gill RD, Keiding N. Statistical Models Based on Counting Processes. New York, NY: Springer; 1993.
34. Rosthøj S, Andersen PK, Abildstrom SZ. SAS macros for estimation of the cumulative incidence functions based on a Cox regression model for competing risks survival data. Comput Meth Programs Biomed. 2004;74: 69-75.
35. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007;26:2389-2430.
36. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. 2nd ed. Hoboken, NJ: Wiley; 2002.
37. Gaynor JJ, Feuer EJ, Tan CC, Wu DH, Little CR, Straus DJ, Clarkson BD, Brennan MF. On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data. J Am Stat Assoc. 1993;88:400-409.
38. Lin D, Wei L, Ying Z. Checking the Cox model with cumulative sums of martingale-based residuals. Biometrika. 1993;80:557-572.
39. Korn EL, Graubard BI, Midhune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of time scale. Am J Epidemiol. 1997;145:72-80.
40. Pencina MJ, Larson MG, D'Agostino RB. Choice of timescale and its effect on significance of predictors in longitudinal studies. Stat Med. 2007;26:1346-1359.
41. Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet. 2008;371:923-931.
42. Wilson PFW, Bozeman SR, Burton TM, Hoaglin DC, Ben-Joseph R, Pashos CL. Prediction of first events of coronary heart disease and stroke with consideration of adiposity. Circulation. 2008;118:124 -130.
43. Harrell FE, Lee KL, Mark DB. Tutorial in biostatistics: multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387.
44. Pencina MJ, D'Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med. 2004;23:2109-2123.
45. D'Agostino RB, Nam BH. Evaluation of the performance of survival analysis models: discrimination and calibration measures. Handbook of Statistics. New York, NY: Elsevier; 2004:1-25.
46. Hastie T, Tibshirani RFJ. The Elements of Statistical Learning. New York, NY: Springer; 2001.
47. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157-172.
48. SAS/STAT Software, Version 9.1, of the SAS System for Windows. Cary, NC: SAS Institute Inc; 2002-2003.
49. Menotti A, Lanti M. Coronary risk factors predicting early and late coronary deaths. Heart. 2003;89:19-24.
50. Wilson PFW, Pencina MJ, Jacques P, Selhub J, D'Agostino RB, O'Donnell CJ. C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study. Circ Cardiovasc Qual Outcomes. 2008;1:92-97.